Accredited CPD Courses

This course is designed to equip nursing professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. DEVELOPER'S NOTE: As nurses, we understand the growing importance of holistic care and the role medical cannabis can have in managing a multitude of conditions. Join us in this meticulously crafted course to explore the history and botany of cannabis, understand the role of the endocannabinoid system and homeostasis. Learn how to navigate TGA processes, monitor and manage potential adverse side effects and other important aspects of cannabis treatment and patient care. This course is created and endorsed by nurses who believe in the potential of medical cannabis as a vital component of integrative, modern healthcare. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Monitor and provide titration advice around cannabinoid medicines.  Apply critical safety considerations in patient centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia.  Claim 5 CPD hours for eligible participants.

This accredited course provides doctors with a comprehensive introduction to the clinical and regulatory foundations of medical cannabis prescribing in Australia. As patient interest in cannabinoid-based therapies increases, it is essential for prescribers to be equipped with evidence-informed knowledge and practical skills to navigate this evolving space safely and effectively. Through this program, participants will explore the endocannabinoid system and its relevance to human physiology, examine the pharmacology of key cannabis constituents, and gain practical insight into initiating, monitoring, and titrating medical cannabis products. The course also addresses the Australian regulatory landscape and offers guidance on assessing patient suitability, facilitating informed discussions, and applying critical safety considerations in clinical practice. Designed to support evidence-based decision-making, this course empowers doctors to responsibly consider medical cannabis as part of a broader, patient-centred approach to managing chronic symptoms and conditions. Preview this course by watching the video above. Estimated Duration: 5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe cannabis medicines accurately and demonstrate an understanding of the individual chemical components of the plant. Demonstrate an understanding of endocannabinoid system function. Assess the suitability of cannabis treatments in various chronic disease states. Identify appropriate patient cohorts for medical cannabis treatment. Facilitate clinical discussions with patients around medical cannabis as a therapeutic option in symptom management. Initiate, monitor and titrate cannabinoid medicines.  Apply critical safety considerations in patient-centred care. Navigate the regulatory frameworks surrounding medical cannabis provision in Australia. 

This course is designed to equip pharmacist professionals with the knowledge and skills necessary to navigate Australia's evolving medical cannabis landscape. Designed for pharmacists, this course will help you gain essential knowledge for safely and effectively handling medical cannabis. Develop a practical understanding of the endocannabinoid system, crucial for dispensing, monitoring, and adjusting cannabinoid medications within Australia's regulations. Understand your distinct role as a pharmacist in patient care, and learn to lead discussions with your patients for their best health outcomes. Join a cohort of passionate pharmacists in Australia who have chosen to broaden their skills in medical cannabis prescribing. With this course, you can be part of improving treatment options for patients suffering from chronic conditions Australia wide.  Preview this course by watching the video above. Estimated Duration: 8 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Discuss the individual components of the cannabis plant Describe cannabis medicine options accurately Explain how the endocannabinoid system functions Assess the suitability of cannabis treatment for various chronic disease states Identify appropriate and inappropriate patient cohorts for medical cannabis treatment Discuss with patients about medical cannabis as a therapeutic option for symptom management Describe how to initiate, monitor and titrate cannabinoid medicines Apply critical safety considerations in patient-centred care Describe the role and responsibilities of pharmacists in relation to medical cannabis therapy Explain how pharmacists can educate patients on safe and effective use of medical cannabis Discuss how to collaborate with other healthcare providers to monitor patient outcomes and adjust treatment plans Describe requirements for storing medical cannabis Discuss quality control measures for medical cannabis products Explain the Australian regulatory frameworks surrounding medical cannabis provision Claim 17 CPD credits for eligible participants.

This course is an intermediate-level exploration of how to tailor medical cannabis treatment for patients by considering their prior exposure to cannabis (medical or otherwise). With a focus on identifying patients' exposure levels, nurses and nurse practitioners will learn to account for patients’ prior cannabis exposure when offering care during medical cannabis treatment. Over the course of 7 modules, discover cannabis’ interactions with the body, as well as the key identifiers, considerations and recommendations for offering safe and effective treatment. Examine the biological composition of cannabis and its pharmacological interactions with the body, gaining insight into how prior exposure affects tolerance and experience. This course forms part of a comprehensive learning path covering factors to consider when offering medical cannabis care and treatment. Preview this course by watching the video above. Estimated Duration: 6 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis’ biological constituents and explain their effects on the body Explain how the endocannabinoid system (ECS) maintains homeostasis and describe cannabis’ interactions with the ECS, including how exposure affects endocannabinoid tone Identify the 2 dimensions of prior cannabis exposure, and explain how to identify them in patients Explain how prior exposure may impact treatment goals and discuss considerations and recommendations for setting personalised treatment goals based on prior exposure Identify and describe common medical cannabis products and explain the considerations and recommendations for product selection based on prior cannabis exposure Discuss general recommendations for dosage and titration based on patient’s prior cannabis exposure

This course is an intermediate-level exploration of how to tailor medical cannabis treatment for patients by considering their prior exposure to cannabis (medical or otherwise). With a focus on identifying patients' exposure levels, doctors will learn to customise care and treatment to safely and effectively unlock the therapeutic benefits of medical cannabis. Over the course of 7 modules, discover cannabis’ interactions with the body, as well as the key identifiers, considerations and recommendations for offering safe and effective treatment. Examine the biological composition of cannabis and its pharmacological interactions with the body, gaining insight into how prior exposure affects tolerance and experience. This course forms part of a comprehensive learning path covering factors to consider when offering medical cannabis care and treatment. Preview this course by watching the video above. Estimated Duration: 6 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis’ biological constituents and explain their effects on the body Explain how the endocannabinoid system (ECS) maintains homeostasis and describe cannabis’ interactions with the ECS, including how exposure affects endocannabinoid tone Identify the 2 dimensions of prior cannabis exposure, and explain how to identify them in patients Explain how prior exposure may impact treatment goals and discuss considerations and recommendations for setting personalised treatment goals based on prior exposure Identify and describe common medical cannabis products and explain the considerations and recommendations for product selection based on prior cannabis exposure Discuss general recommendations for dosage and titration based on patient’s prior cannabis exposure

This course is an intermediate-level exploration of how to tailor medical cannabis dispensing for patients by considering their prior exposure to cannabis (medical or otherwise). With a focus on identifying patients' exposure levels, pharmacists will learn to account for patients’ prior cannabis exposure when dispensing medical cannabis products to patients. Over the course of 7 modules, discover cannabis’ interactions with the body, as well as the key identifiers, considerations and recommendations for safely dispensing medical cannabis products to patients. Examine the biological composition of cannabis and its pharmacological interactions with the body, gaining insight into how prior exposure affects tolerance and experience. This course forms part of a comprehensive learning path covering factors to consider when offering medical cannabis care and treatment. Preview this course by watching the video above. Estimated Duration: 3.5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify cannabis’ biological constituents and explain their effects on the body Explain how the endocannabinoid system (ECS) maintains homeostasis and describe cannabis’ interactions with the ECS, including how exposure affects endocannabinoid tone Identify the 2 dimensions of prior cannabis exposure, and explain how to identify them in patients Explain how prior exposure may impact treatment goals and discuss considerations and recommendations for setting personalised treatment goals based on prior exposure Identify and describe common medical cannabis products and explain the considerations and recommendations for product selection based on prior cannabis exposure Discuss general recommendations for dosage and titration based on patient’s prior cannabis exposure

Designed for nurses, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go under-recognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks. With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause Additionally, it covers critical pregnancy-related contraindications for medical cannabis. Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes. This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients. Preview this course by watching the video above. Estimated Duration: 1 hour Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Assess medical cannabis’ therapeutic potential for treating symptoms of dysmenorrhoea, endometriosis, PCOS, PMDD, PPD, menopause, and breast, ovarian and uterine cancers considering its pharmacological interaction with the condition’s pathophysiology and efficacy, and drawbacks of current recommended treatments Identify characteristics of suitable medical cannabis strains, compounds, product types and administration methods for treating symptoms of the particular condition affecting IAFABP Identify and explain pregnancy-related contraindications for using medical cannabis

Designed for doctors, this course explores a range of health conditions that disproportionately affect people assigned female at birth and intersex individuals with female reproductive organs—many of which are historically under-recognised and undertreated. These conditions can significantly impact physical, mental, and reproductive health, often requiring nuanced, multidisciplinary approaches. With medical cannabis emerging as a potential adjunct for symptom management, this course provides evidence-based insights into its role across conditions including: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause The course also addresses key safety considerations, including contraindications during pregnancy and lactation. Clinicians will leave with a deeper understanding of how to safely integrate medical cannabis into patient-centred care plans alongside conventional therapies. Preview this course by watching the video above. Estimated Duration: 5.5 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Describe and explain the causes, symptoms, effects, and risk factors for various reproductive health conditions, including perimenopause, menopause, breast, ovarian, and uterine cancers, dysmenorrhoea, endometriosis, polycystic ovarian syndrome (PCOS), premenstrual dysphoric disorder (PMDD), and postpartum depression (PPD) Identify and evaluate common conventional treatment options for these conditions and their potential drawbacks Discuss the therapeutic potential of medical cannabis for treating symptoms of these reproductive health conditions Identify considerations for selecting suitable medical cannabis products for treating symptoms related to these conditions Identify TGA guidelines on contraindications for medical cannabis use during pregnancy and chest-feeding Discuss potential short and long-term risks of early cannabis exposure Explain the role of the endocannabinoid system in reproductive function Describe the risks of cannabis use during pregnancy, planning to become pregnant, and postnatal phases for both the foetus or infant and the birth-giver

Designed for pharmacists, this course delves into a range of conditions that are uniquely prevalent among people assigned female at birth and intersex individuals with female reproductive organs. These conditions often go under-recognised and can profoundly affect health and quality of life. Conventional treatments sometimes fail to fully address these issues and can carry significant risks. With medical cannabis emerging as a promising alternative, this course offers evidence-based insights into its potential for managing symptoms of: Endometriosis Dysmenorrhoea Polycystic Ovary Syndrome (PCOS) Premenstrual Dysphoric Disorder (PMDD) Postpartum Depression (PPD) Breast, ovarian, and uterine cancers Perimenopause and menopause Additionally, it covers critical pregnancy-related contraindications for medical cannabis. Healthcare professionals will gain crucial knowledge and skills to expand their therapeutic toolkit, integrating both traditional and cannabis-based approaches to enhance patient outcomes. This is an opportunity to stay at the forefront of medical advancements and provide innovative care options for your patients. Preview this course by watching the video above. Estimated Duration: 4 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Assess when and how medical cannabis may improve treatment outcomes for IAFABP Make informed recommendations to patients and their doctors around medical cannabis as a treatment option Deliver exceptional patient-centred care by understanding your patients' experiences and exploring their options, you will be equipped to offer compassionate, professional and attentive care when your patients ask questions or come to dispense their medications

While well-known systems like the sympathetic nervous system are widely understood, doctors may be less familiar with the more recently identified endocannabinoid system (ECS).1,2 The ECS is thought to be involved in regulating pain, immunity, stress, appetite, weight, and nausea, yet it remains largely absent from traditional medical education in Australia.3 What will you learn?This module aims to equip you with the skills and confidence to integrate medical cannabis into patient care when clinically appropriate. Drawing on current evidence and theoretical case studies, the module explores the ECS, cannabinoid pharmacology, proposed therapeutic effects, and the clinical implications of both ECS function and use of medical cannabis. Through interactive scenarios and evidence summaries, you’ll explore how this knowledge may be relevant to clinical applications—ranging from the potential involvement of the ECS in patient presentations to identifying possible treatment approaches. Estimated Duration: 4 hours Access Duration: 12 months from date of purchase Learning Outcomes Upon completion of this module, you’ll be able to: Identify the endocannabinoid system’s components, role and functions, as currently understood Describe how endocannabinoid system function and dysfunction may contribute to symptoms such as pain, anxiety, sleep disturbance and inflammation Interpret how the mechanism of the endocannabinoid system may inform the therapeutic potential of medical cannabis Explain the pharmacological effects of THC and CBD Identify clinical features suggestive of cannabinoid tolerance or receptor desensitisation Describe the limitations and uncertainties in the current evidence relating to the endocannabinoid system References Harvard Health Publishing. The endocannabinoid system: Essential and mysterious. https://www.health.harvard.edu/blog/the-endocannabinoid-system-essential-and-mysterious-202108112569 (accessed Aug 2025). Parliament of Australia. Current barriers to patient access to medicinal cannabis in Australia. https://parlinfo.aph.gov.au/parlInfo/download/committees/reportsen/024403/toc_pdf/CurrentbarrierstopatientaccesstomedicinalcannabisinAustralia.pdf (accessed Aug 2025). Hillard CJ. Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? Neuropsychopharmacology. 2018;43:155–172.